The Company has decided on the total dividend amount of 5,903 million yen with effective date of June 22, 2026, and has increased the dividend per share to 60 yen. This is an increase of 8 yen from the previous year’s same period of 52 yen, with a payout ratio of 40.3%.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4401","jir_company_name":"Takeda Pharmaceutical Company Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4401-20260514-03.pdf","jir_short_summary":"The Company has decided on the total dividend amount of 5,903 million yen with effective date of June 22, 2026, and has increased the dividend per share to 60 yen. This is an increase of 8 yen from the previous year's same period of 52 yen, with a payout ratio of 40.3%.","jir_summary":"### Dividend Overview\nTakeda Pharmaceutical Company Limited has decided on a total dividend of 5,903 million yen for the fiscal year ending March 2026, increasing the dividend per share to 60 yen. This reflects an increase of 8 yen from the previous year's 52 yen, with a payout ratio of 40.3%. The effective date is scheduled for June 22, 2026, demonstrating the company's commitment to returning value to shareholders.\n\n### Future Outlook and Impact on Shareholders\nThe dividend increase is expected to enhance shareholder returns and boost investment appeal. Takeda Pharmaceutical intends to maintain a stable dividend policy going forward and aims to improve shareholder value. The increase in dividends is positioned as part of the company's sound financial condition and growth strategy.","jir_financial_highlights":"Total Dividends: 5,903 million yen (Compared to previous year +586 million yen)\nDividend per Share: 60 yen (Compared to previous year +8 yen)\nPayout Ratio: 40.3% (Compared to previous year +0.6 percentage points)","jir_category":"","jir_hashtags":"#TakedaPharmaceutical, #Dividend, #JapanStocks","jir_key_figures":"Total Dividends: 5,903 million yen (Compared to previous year +586 million yen)\nDividend per Share: 60 yen (Compared to previous year +8 yen)\nPayout Ratio: 40.3% (Compared to previous year +0.6 percentage points)","jir_meta_title":"\u3010Takeda Pharmaceutical\u3011Dividend Increase\uff5cEffective Date June 22, 2026","jir_meta_description":"Takeda Pharmaceutical has decided to increase its total dividend to 5,903 million yen and dividend per share to 60 yen as of June 22, 2026, strengthening shareholder returns.","jir_og_title":"\u3010Takeda Pharmaceutical\u3011Dividend Increase\uff5cEffective Date June 22, 2026","jir_og_description":"Takeda Pharmaceutical is increasing dividends and strengthening shareholder returns, with an effective date of June 22, 2026.","jir_og_image_url":"\/assets\/og\/company-dividend.jpg","jir_chart_data_collection":"[]","ir_related_company":7996,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-49815","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n